ArticleJournal of materials science2025
Tunable and scalable production of nanostar particle platforms for diverse applications using an AI-integrated automated synthesis system.
Article in Journal of materials science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-driven nanomedicine for cancer theranostics.Molecular cancer · 2026Review
- Advancing precision photothermal therapy by integrating armored gold nanostars with real-time photoacoustic thermometry and imaging.Science advances · 2025Article
- Engineering plasmonic Au nanostars: Enhanced plasmonic properties, preparation and biomedical application.Materials today. Bio · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The tunable optical properties and exceptional electromagnetic field enhancement of nanostar-based plasmonic nanoparticles have garnered much attention for use in a wide array of biomedical applications. However, a great challenge for their widespread use is the time-sensitive nature of nanostar synthesis, which could lead to unprecise control of their homogeneity and high batch-to-batch variability. We have developed an automated synthesis system with AI capability to reproducibly synthesize large quantities of nanostar particles. Using this platform, synthesis parameters such as reagent volume and reagent addition timing can be varied to observe how these factors determine the optical properties and SERS enhancement of gold nanostars and bimetallic nanostars, which are used as two model systems. An artificial intelligence (AI) system based on two tree-based machine learning models was developed and trained using nanoparticle characterization data to predict absorbance features and SERS enhancement from synthesis parameters. A grid matrix was fed into the final trained models to create a lookup table to synthesize gold nanostars with an absorbance maximum at specific wavelengths, culminating in the reproducible synthesis of desired nanostar platforms with a peak absorbance wavelength of less than 1.2% difference compared to the target peak absorbance. This machine learning-integrated automated synthesis platform has the potential to enable the next phase of investigation for nanostar-based technologies and expand the scope of their current applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.